HomeCompareTRSFF vs MRK

TRSFF vs MRK: Dividend Comparison 2026

TRSFF yields 5263.16% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRSFF wins by $102432968530093.38M in total portfolio value
10 years
TRSFF
TRSFF
● Live price
5263.16%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102432968530093.42M
Annual income
$98,742,385,398,383,070,000.00
Full TRSFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TRSFF vs MRK

📍 TRSFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRSFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRSFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRSFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRSFF
Annual income on $10K today (after 15% tax)
$447,368.42/yr
After 10yr DRIP, annual income (after tax)
$83,931,027,588,625,610,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TRSFF beats the other by $83,931,027,588,625,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRSFF + MRK for your $10,000?

TRSFF: 50%MRK: 50%
100% MRK50/50100% TRSFF
Portfolio after 10yr
$51216484265046.73M
Annual income
$49,371,192,699,191,540,000.00/yr
Blended yield
96.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TRSFF
No analyst data
Altman Z
-7.4
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRSFF buys
0
MRK buys
0
No recent congressional trades found for TRSFF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRSFFMRK
Forward yield5263.16%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$102432968530093.42M$56.8K
Annual income after 10y$98,742,385,398,383,070,000.00$9,798.13
Total dividends collected$102183681196311.97M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TRSFF vs MRK ($10,000, DRIP)

YearTRSFF PortfolioTRSFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$537,016$526,315.79$11,206$366.19+$525.8KTRSFF
2$26,989,550$26,414,942.92$12,650$502.35+$26.98MTRSFF
3$1,269,600,822$1,240,722,003.32$14,407$694.19+$1269.59MTRSFF
4$55,904,391,573$54,545,918,693.73$16,585$967.82+$55904.37MTRSFF
5$2,304,512,049,686$2,244,694,350,703.24$19,342$1,363.89+$2304512.03MTRSFF
6$88,943,998,518,419$86,478,170,625,254.53$22,913$1,947.19+$88943998.50MTRSFF
7$3,214,493,329,356,589$3,119,323,250,941,881.00$27,662$2,823.89+$3214493329.33MTRSFF
8$108,798,712,659,598,690$105,359,204,797,187,140.00$34,159$4,173.35+$108798712659.56MTRSFF
9$3,449,143,113,747,977,000$3,332,728,491,202,206,700.00$43,337$6,308.80+$3449143113747.93MTRSFF
10$102,432,968,530,093,420,000$98,742,385,398,383,070,000.00$56,776$9,798.13+$102432968530093.38MTRSFF

TRSFF vs MRK: Complete Analysis 2026

TRSFFStock

Tres-Or Resources Ltd., a resource company, engages in the exploration and development of mineral properties in Canada. The company explores for gold, diamond, and base metal properties. Its flagship project is Quebec Diamond project located in Témiscamingue region in southwestern, Quebec. The company was incorporated in 1986 and is headquartered in Vancouver, Canada.

Full TRSFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TRSFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRSFF vs SCHDTRSFF vs JEPITRSFF vs OTRSFF vs KOTRSFF vs MAINTRSFF vs JNJTRSFF vs ABBVTRSFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.